Modern Diagnostic IPO Analyzed: Key Investor Demand

The initial public offering (IPO) for Modern Diagnostic & Research Centre, a company providing medical testing services, is proving incredibly popular. Investors have shown a huge amount of interest, with the subscription window closing today, January 2, 2026. This strong demand is a good sign for the company’s future.

Key Points

• Strong investor interest led to oversubscription of 39.61x in NII.
• Retail investors showed huge demand, subscribing 33.85 times.
• Qualified Institutional Buyers (QIBs) subscribed 8.94 times.
• Grey market premiums indicate a 15.56% premium over the offer price.
• The IPO offers 4.1 million shares priced between ₹85 and ₹90.
• Funds will be used for equipment, working capital and debt repayment.

Details of the IPO

Modern Diagnostic is offering 4.1 million new shares to the public. The price range is from ₹85 to ₹90 per share, and you need at least 3,200 shares (two lots) to buy them. This means a retail investor would need around ₹2.88 lakh to apply.

The company plans to use the money it raises from the IPO to buy new medical equipment for its testing centers. It will also use some of the money to pay off debts and have extra funds for general business activities. The shares are expected to be listed on the BSE SME platform on January 7, 2026.

As of now, the company will decide who gets shares on Monday, January 5, 2026. Investors will receive their shares on Tuesday, January 6, 2026.

Strong investor demand signals confidence in Modern Diagnostic’s growth potential and the broader diagnostic services market.